Xcout Intel
AQEMIA
AQEMIA is a French technology company that uses quantum-inspired algorithms and artificial intelligence for drug discovery. It develops therapeutic candidates and works with pharmaceutical and biotechnology companies to accelerate the design of new medicines.
Subscribe to see AQEMIA’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AQEMIA at a glance
AQEMIA is a deep tech company headquartered in France. Its most recent funding round, Series A, raised $38M in December 2024. Xcout tracks 1 named person at AQEMIA, including Maximilien Levesque (CEO and co-founder). Xcout recorded 1 job posting from AQEMIA in the last 90 days.
AQEMIA leadership
- Maximilien LevesqueCEO and co-founder
AQEMIA funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $38M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at AQEMIA
Xcout recorded 1 job posting from AQEMIA in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see AQEMIA's hiring signals →
Investors
AQEMIA competitors
A few of AQEMIA's closest competitors — see the full list of competitors and alternatives →
Atinary is an artificial intelligence company with operations in Silicon Valley and Switzerland, featuring headquarters in Menlo Park, California. The company provides a code-free AI platform that accelerates research, development, and discovery in molecular science and chemistry.
Kebotix is a technology company founded in 2017 and headquartered in Cambridge, Massachusetts. The firm is dedicated to tackling major scientific challenges by leveraging advanced digital tools and artificial intelligence to revolutionize research and development in materials science.
Generare is a biotechnology and artificial intelligence company headquartered in Paris, France, focused on commercial bioprospecting and decoding natural products.
Rahko is a United Kingdom-based company founded in 2018 that specializes in quantum machine learning and quantum-inspired machine learning for drug discovery. The private company was subsequently acquired by Odyssey Therapeutics to integrate its technology into drug discovery platforms.
Altrove is an artificial intelligence startup headquartered in Paris, France. The company applies advanced physical and AI technologies to develop innovative materials and research solutions.
Quercus Biosolutions is a biotechnology company headquartered in Saint Louis, Missouri, that uses generative artificial intelligence to develop biology-based crop protection solutions.
Get AQEMIA's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on AQEMIA in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access